A carregar...
Publicação
Acute coronary syndrome in the oncology patient
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 505.8 KB | Adobe PDF |
Orientador(es)
Resumo(s)
5-Flurouracil is a first-line agent in several cancer-therapy regimens. Cardiotoxicity is common, with coronary artery disease being an important risk factor. We report the case of an acute coronary syndrome presumably induced by 5-FU, in a patient with previously unknown and asymptomatic coronary artery disease, with and estimated intermediate risk for cardiovascular events. Pre-chemotherapy risk evaluation and optimal patient care are still not standardized in this clinical scenario.
Descrição
Copyright © 2018 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L.U. All rights reserved.
Palavras-chave
5‐FU Angina Pectoris Angina pectoris Cardiotoxicidade Cardiotoxicity SDG 3 - Good Health and Well-being